Pulmonary Artery Doppler and Neonatal Outcome in Placenta Accreta Spectrum Patients

CompletedOBSERVATIONAL
Enrollment

71

Participants

Timeline

Start Date

August 15, 2021

Primary Completion Date

August 1, 2022

Study Completion Date

September 1, 2022

Conditions
Placenta Accreta
Interventions
DEVICE

ultrasonography

"A full obstetric ultrasound scan will be performed to assess signs of placental invasion, to document fetal biometry, estimated fetal weight, amniotic fluid index, assess fetal lung maturity parameters as pulmonary artery Doppler waveforms, amniotic fluid free floating particles, bowel echogenicity, fetal epiphyseal ossific centers, liver/lung echogenicity and kidney length.~Pulmonary artery Doppler: Fetal echocardiography will be done. Pulmonary artery Doppler flow waveforms, including pulsatility index, resistance index, systolic-to-diastolic ratio, peak systolic velocity, and acceleration time to ejection time ratio will be measured in the main pulmonary artery."

Trial Locations (1)

Unknown

Kasralainy Cairo University, Giza

All Listed Sponsors
lead

Cairo University

OTHER

NCT04911322 - Pulmonary Artery Doppler and Neonatal Outcome in Placenta Accreta Spectrum Patients | Biotech Hunter | Biotech Hunter